Joshua Ismin

Co-founder, CEO @Xylo Bio

San Francisco, CA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2021 — Present

Co-founder, CEO @Xylo Bio

View department →

Boulder, CO, US

Xylo Bio is a pioneering biotech company dedicated to transforming lives with targeted neurotherapeutics. By leveraging advanced neuroscience and a computational drug discovery platform, Xylo is developing neuroplastogens – targeted small molecule therapies designed to rewire neural circuits and restore brain function in patients suffering from psychiatric and neurological disorders. I co-founded the company in 2021 as Psylo, we rebranded to Xylo Bio in 2025 to reflect our sharpened focus on neuroplastogens.

EDUCATION

2002 — 2005

Washington University in St. Louis - Olin Business School

MBA, Marketing & Entrepreneurship

N/A

Washington University in St. Louis

BSBA, Minor in computer science

SKILLS

Online Advertising

ABOUT JOSHUA ISMIN

Repeat founder, ocean swimmer, co-founder of Xylo Bio

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Joshua Ismin — Co-founder, CEO at Xylo Bio in San Francisco, CA, US | Unifers